SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-017270
Filing Date
2018-06-19
Accepted
2018-06-19 21:33:42
Documents
2
Period of Report
2018-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3904
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4451
  Complete submission text file 0000899243-18-017270.txt   9735
Mailing Address C/O CIVITAS THERAPEUTICS, INC. 190 EVERETT AVENUE CHELSEA MA 02150
Business Address
Shah Rajeev M. (Reporting) CIK: 0001619841 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38533 | Film No.: 18908546

Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Issuer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations